½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1326473

¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå - »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø(2018-2028³â)

Self Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By Sample, By Usage, By Distribution Channel, By Region and Competition

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÀÚ°¡ °Ë»ç(Self Testing) ½ÃÀåÀº ´«ºÎ½Å ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº ÀÌ·¯ÇÑ Á¦Ç° ÆíÀǼº°ú Á¢±Ù¼º, º¸´Ù Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ±â¼ú ¹ßÀüÀ¸·Î Á¡Á¡ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÀÌ·¯ÇÑ Á¦Ç°ÀÌ Á¦°øÇÏ´Â ÆíÀǼº°ú Á¢±Ù¼ºÀÔ´Ï´Ù. ¼ÒºñÀÚ´Â ÇöÀç °Ç°­ °ü¸® Àü¹®°¡¸¦ ÇÊ¿ä·Î ÇÏÁö ¾ÊÀ¸¸ç Áý¿¡ ÀÖ´Â µ¿¾È ÀڽŠ°Ç°­À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÆíÀǼºÀº ¹Ù»Û ÀÏÁ¤À̳ª À̵¿ ¹®Á¦°¡ Àְųª ¿ø°ÝÁö¿¡ »ç´Â »ç¶÷µé¿¡°Ô ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. ¶ÇÇÑ ¼¼°èÀÇ »ç¶÷µé »çÀÌ¿¡¼­ °Ç°­°ú À£ºù ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ´Â ÀڽŠ°Ç°­¿¡ ´ëÇØ ´õ Àû±ØÀûÀ¸·Î »ý°¢ÇÏ°í ÀڽŠ°Ç°­À» ¸ð´ÏÅ͸µÇÏ°í °³¼±ÇÏ´Â ¹æ¹ýÀ» ã°í ÀÖ½À´Ï´Ù. ÀÚ°¡ °Ë»ç Á¦Ç°Àº Ç÷´ç, ÄÝ·¹½ºÅ×·Ñ, Ç÷¾Ð°ú °°Àº °Ç°­ ÁöÇ¥¸¦ ÃßÀûÇÏ´Â Æí¸®ÇÑ ¹æ¹ýÀ» Á¦°øÇϸç, ¼ÒºñÀÚ°¡ ÀڽŠ°Ç°­ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ¿¡ Àǻ縦 °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ°ÍÀÌ ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ÇÕ¸®ÀûÀÎ °¡°Ý

ÀÚü °Ë»ç Á¦Ç°Àº ÀüÅëÀûÀÎ °Ç°­ °ü¸® ¼­ºñ½ºº¸´Ù ºñ¿ë È¿À²ÀûÀÎ °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ´Â °í¾× ÀÇ·á °Ë»ç³ª ÀÇ»ç ÁøÂû¿¡ µ·À» ÁöºÒÇÏ´Â ´ë½Å Áý ÀڽŠ°Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÏ¿© µ·À» Àý¾àÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠÀÚü °Ë»ç Á¦Ç°Àº º¸ÇèÀÌ Àû¿ëµÇ¹Ç·Î ¼ÒºñÀÚ ºÎ´ãÀÌ ´õ¿í ÁÙ¾îµì´Ï´Ù. ÀÌ°ÍÀº ¾ÕÀ¸·Î ¸î ³â°£ ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ö¿ä¸¦ Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³ÀÎÈ­

¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀåÀº ÀÌ·¯ÇÑ Á¦Ç°ÀÌ Á¦°øÇÏ´Â °³ÀÎÈ­¿¡ ÀÇÇØ Áö³­ ¸î ³â°£ ¼ºÀåÇØ ¿Ô½À´Ï´Ù. ¼ÒºñÀÚ´Â ´ç´¢º´ °ü¸®¸¦ À§ÇÑ Ç÷´çÄ¡ ¸ð´ÏÅ͸µ°ú ºÒÀÓ Ä¡·á °èȹÀ» À§ÇÑ ¹è¶õ ÃßÀû°ú °°Àº °³º° ¿ä±¸¿¡ ºÎÀÀÇÏ´Â ±¤¹üÀ§ÇÑ Àڱ⠰˻ç Á¦Ç° Áß ¼±ÅÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³ÀÎÈ­¸¦ ÅëÇØ ¼ÒºñÀÚ´Â ÀڽŠ°Ç°­À» °ü¸®ÇÏ°í ÀڽŠ»óȲ¿¡ µû¶ó Á¤º¸¸¦ ±â¹ÝÀ¸·Î °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡, °Ë»ç °á°ú´Â °Ë»ç¸¦ ¹ÞÀº º»ÀÎ ÀÌ¿Ü¿¡´Â ¸ð¸£±â ¶§¹®¿¡ ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ºÀåÀ» ÁöÁöÇÏ°í ÀÖ½À´Ï´Ù.

¸¸¼º Áúȯ À¯º´·ü Áõ°¡

½ÉÇ÷°ü Áúȯ ¹× ´ç´¢º´°ú °°Àº¸¸¼º Áúȯ À¯º´·ü Áõ°¡´Â 2028³â ÀÚü °Ë»ç ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹¿¡´Â ¼¼°èÀÇ 3À§ ´ç´¢º´ Àα¸°¡ Á¸ÀçÇÕ´Ï´Ù. ¹Ì±¹Àº ¾à 3,030¸¸ ¸í ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, ÀÌ´Â ¼ºÀÎ °ÅÀÇ 10¸í Áß 1¸í¿¡ ÇØ´çÇÕ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº ¹Ì±¹ ÁÖ¿ä »ç¸Á ¿øÀÎÀ̸ç 2019³â ¾à 659,041¸íÀÌ »ç¸ÁÇÑ °ÍÀ¸·Î º¸°íµÇ¾ú½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ ÁÖ¿ä ¿äÀÎÀº ´ç´¢º´°ú °íÄÝ·¹½ºÅ×·ÑÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÀ¯·Î ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå Ç÷´çÄ¡ °Ë»ç¿Í ÄÝ·¹½ºÅ×·Ñ °Ë»ç ºÐ¾ß ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ø°Ý ÀÇ·á äÅà Ȯ´ë

¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ äÅà Ȯ´ë·Î ÀçÅà °Ë»ç Å°Æ® ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ¼¼°èÀÇ ÀÚ±â Áø´Ü ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á ÃâÇö, ƯÈ÷ Ç÷´çÄ¡¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇØ¾ß ÇÏ´Â ´ç´¢º´ ȯÀÚÀÇ °æ¿ì, ȯÀÚ´Â °¡Á¤ Áø´ÜÀ¸·Î ÀüȯÇÏ°Ô µË´Ï´Ù. ÀçÅà °Ë»ç Å°Æ®¸¦ »ç¿ëÇÏ´Â ´ç´¢º´ ȯÀÚ´Â Áý Ç÷´çÀ» È®ÀÎÇÏ°í ÀüÈ­³ª È­»ó ÅëÈ­·Î ÀÇ»ç¿Í »ó´ãÇÕ´Ï´Ù. ±× °á°ú ȯÀÚ°¡ Ŭ¸®´ÐÀ̳ª º´¿øÀ» ¹æ¹®ÇÒ Çʿ伺ÀÌ ÁÙ¾îµé¾ú½À´Ï´Ù. ´ç´¢º´ Àα¸ Áõ°¡´Â ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ºÀåÀ» ´õ¿í Çâ»ó½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±¹Á¦ ´ç´¢º´ ¿¬ÇÕ¿¡ µû¸£¸é 2021³â ÇöÀç ¾à 5¾ï 3,700¸¸ ¸í ¼ºÀÎ(20-79¼¼)ÀÌ ´ç´¢º´À» ¾Î°í ÀÖ½À´Ï´Ù. ´ç´¢º´ ȯÀÚ ÃÑ ¼ö´Â 2030³â 6¾ï 4,300¸¸ ¸í, 2045³â 7¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯ÀüÀÚ °Ë»ç

À¯ÀüÇÐÀû °Ë»çµµ ÃÖ±Ù ³Î¸® ½Ç½ÃµÇ°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ À¯ÀüÀû Ư¡°ú °Ç°­ ¸®½ºÅ©¿¡ °üÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Â °Ë»ç°¡ °¢»ç·ÎºÎÅÍ Á¦°øµË´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â Áý¿¡¼­ ¼öÇàÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ´Â ÀڽŠÀ¯ÀüÀû üÁú¿¡ ´ëÇØ °³ÀÎÈ­µÈ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¤º¸´Â ¶óÀÌÇÁ ½ºÅ¸ÀÏÀ» ¹Ù²Ù°Å³ª ÀÇ·á °³ÀÔÀ» ¿ä±¸ÇÏ´Â µî °Ç°­°ú À£ºù ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î °áÁ¤À» ³»¸®´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

À¯ÀüÀÚ °Ë»ç´Â »ç¶÷µéÀÌ ÀڽŠ°Ç°­°ú °¡°è¸¦ ´õ Àß ÀÌÇØÇÏ°íÀÚ ÇÔ¿¡ µû¶ó ÃÖ±Ù ¸î ³â°£ Á¡Á¡ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀüÀ¸·Î °³ÀÎÀÌ ¿Â¶óÀÎÀ¸·Î À¯ÀüÀÚ °Ë»ç Å°Æ®¸¦ ÁÖ¹®ÇÏ°í Áý Æí¾ÈÇÏ°Ô °Ë»ç¸¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¡Á¤¿ë À¯ÀüÀÚ °Ë»ç Á¦Ç°Àº »ç¶÷µéÀÌ ÀڽŠÀ¯ÀüÀû üÁú°ú ÀáÀç °Ç°­ À§Çè¿¡ ´ëÇØ ´õ ÀÚ¼¼È÷ ¾Ë ¼ö ÀÖ´Â Æí¸®ÇÏ°í Àú·ÅÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. 23andMe, AncestryDNA, MyHeritage µî Áý »ç¿ëÇÒ ¼ö ÀÖ´Â À¯ÀüÀÚ °Ë»ç Å°Æ®¸¦ Á¦°øÇϴ ȸ»ç´Â ¸¹ÀÌ ÀÖ½À´Ï´Ù. 23andMe, AncestryDNA, MyHeritage µîÀÔ´Ï´Ù. ÀÌ È¸»ç´Â DNA »ùÇÃÀ» Á¦°øÇÏ´Â °£´ÜÇÑ Å¸¾× ¼öÁý Å°Æ®¸¦ °³Àο¡°Ô Á¦°øÇÕ´Ï´Ù. »ùÇÃÀº ºÐ¼®À» À§ÇØ ½ÇÇè½Ç·Î º¸³»Áö°í ÀϹÝÀûÀ¸·Î ¸î ÁÖ À̳»¿¡ °á°ú°¡ ³ª¿É´Ï´Ù. ÀÌ È¸»ç°¡ Á¦°øÇÏ´Â °Ë»ç´Â °³ÀÎ À¯ÀüÀû ±¸¼º dzºÎÇÑ Á¤º¸¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´, À¯¹æ¾Ï µî ƯÁ¤ Áúº´ À§Çè »ó½Â°ú °ü·ÃµÈ ƯÁ¤ À¯ÀüÀÚ º¯ÀÌü¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³ÀÎ Á¶»ó°ú °¡°è Á¤º¸¸¦ Á¦°øÇÒ ¼ö ÀÖÀ¸¹Ç·Î °¡Á· ¿ª»ç¸¦ ÃßÀûÇÏ´Â µ¥ °ü½ÉÀÌ ÀÖ´Â »ç¶÷µé¿¡°Ôµµ µµ¿òÀÌ µË´Ï´Ù. ÀÌ°ÍÀº ¼¼°èÀÇ ÀÚ±â °Ë»ç ½ÃÀå ¼ºÀå¿¡ »õ·Î¿î Àü¸ÁÀ» °¡Á®¿Ã °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

»ç¿ë °¡´ÉÇÑ »ç¿ëÀÚ Á¤ÀÇ

TechSci Research´Â ÁÖ¾îÁø ½ÃÀå µ¥ÀÌÅ͸¦ ¹ÙÅÁÀ¸·Î ±â¾÷ °íÀ¯ ¿ä±¸¿¡ ¸Â´Â ¸ÂÃã¼³Á¤À» Á¦°øÇÕ´Ï´Ù. º¸°í¼­´Â ´ÙÀ½À» »ç¿ëÀÚ Á¤ÀÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¾÷ Á¤º¸

  • Ãß°¡ ½ÃÀå ÁøÃâ±â¾÷(ÃÖ´ë 5»ç) »ó¼¼ ºÐ¼®°ú ÇÁ·ÎÆÄÀϸµ

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ ÀÇ°ß

Á¦5Àå ÀÚ°¡ °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • Áö¿ªº°
    • ±â¾÷º°(2022³â)
  • Á¦Ç° ¸Ê
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • ÆǸŠä³Îº°
    • Áö¿ªº°

Á¦6Àå ºÏ¹Ì ÀÚ±â °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • ±¹°¡º°
  • ºÏ¹Ìº° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦7Àå À¯·´ ÀÚ±â °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • ±¹°¡º°
  • À¯·´ ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÚ±â °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦9Àå ³²¹Ì ÀÚ±â °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • ±¹°¡º°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÀÚ±â °Ë»ç ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • °Ë»ç À¯Çüº°
    • »ùÇú°
    • ¿ëµµº°
    • À¯Åë ä³Îº°
    • ±¹°¡º°
  • MEA : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø ¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±Ù Àü°³
  • ÇÕº´, Àμö
  • Á¦Ç° ¹ßÇ¥

Á¦13Àå ¼¼°èÀÇ ÀÚ°¡ °Ë»ç ½ÃÀå SWOT ºÐ¼®

Á¦14Àå Æ÷ÅÍÀÇ 5¼¼·Â ºÐ¼®

  • ¾÷°è ³» °æÀï
  • ½Å±Ô ÁøÀÔ °¡´É¼º
  • °ø±ÞÀÚ Èû
  • °í°´ Èû
  • ´ëüǰ À§Çù

Á¦15Àå °æÀï ±¸µµ

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Lucira Health, Inc.
    • Essenlix Corporation
    • Abbott Laboratories, Inc.
    • Quidel Corporation
    • ACON Laboratories, Inc.
    • Scanwell Health, Inc.
    • Johnson& Johnson
    • Geratherm Medical AG
    • B. Braun Holding GmbH
    • OraSure Technologies, Inc.
    • bioLytical Laboratories Inc.
    • Bionime Corporation
    • Becton, Dickinson& Company
    • PRIMA Lab SA
    • F. Hoffmann-La Roche AG

Á¦16Àå Àü·« Á¦¾È

NJH 23.08.28

Global Self Testing Market is expected to grow at an impressive rate during the forecast period. This market has become increasingly popular due to the convenience and accessibility of these products, as well as advances in technology that have made them more accurate and reliable. One of the primary factors driving the growth of the global self-testing market is the convenience and accessibility that these products offer. Consumers can now monitor their health from the comfort of their own homes without the need for a healthcare professional. This convenience is particularly attractive for those with busy schedules, mobility issues, or who live in remote areas. Additionally, the increasing awareness of health and wellness among the population worldwide. Consumers are becoming more proactive about their health and are seeking out ways to monitor and improve their well-being. Self-testing products provide a convenient way to track health indicators such as blood sugar, cholesterol, and blood pressure, which can help consumers make informed decisions about their health. This, in turn, is expected to support the growth of global self-testing market.

Affordability

Self-testing products are often more cost-effective than traditional healthcare services, which has also contributed to their popularity. Consumers can save money by monitoring their health at home instead of paying for expensive medical tests or doctor's visits. Additionally, some self-testing products are covered by insurance, which further reduces costs for consumers. This, in turn, is expected to support the demand for global self-testing market in the coming years.

Personalization

Global self-testing market has grown over the last few years due to the personalization that these products offer. Consumers can choose from a wide range of self-testing products that cater to their individual needs, such as monitoring blood sugar levels for diabetes management or tracking ovulation for fertility planning. This personalization allows consumers to take control of their health and make informed decisions based on their unique circumstances. Additionally, the test results are also not known to anyone else except the one opting for the test, thereby supporting the growth of global self-testing market.

The self-testing kits are highly useful in fertility testing. Home testing kits can provide information on ovulation and fertility status, enabling women to plan their families and make informed decisions about their reproductive health. Fertility testing has traditionally been performed in a clinical setting, but new products have made it possible for women to test their fertility at home. This, in turn, is expected to drive the growth of global self-testing market.

Growing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as cardiovascular diseases and diabetes is expected to support the self-testing market growth through 2028. The United States is home to the world's third-largest diabetic population. Around 30.3 million adults in the United States are suffering from diabetes which is almost 1 in 10 adults. Cardiovascular diseases are the leading cause of death in the United States, with around 659,041 reported deaths in 2019. The major factors contributing to cardiovascular diseases are diabetes and high cholesterol. This, in turn, is expected to increase the demand for blood glucose testing and cholesterol testing segment of global self-testing market.

Growing Adoption of Telemedicine

The growing adoption of telemedicine and remote patient monitoring increased the demand for at-home testing kits, thereby driving the growth of global self-diagnostics market. The advent of telemedicine made patients switch to at-home diagnostics, especially in the case of patients suffering from diabetes who continuously need to monitor their blood glucose levels. Diabetic patients using at-home testing kits check their blood glucose levels at home and then consult their doctor over the phone or video call. This, in turn, has reduced the need for patients to visit clinics and hospitals. The growing diabetic population will further support the growth of global self-testing market. According to International Diabetes Federation, as of 2021, Approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Genetic Testing

Genetic testing has also become more widely available in recent years, with companies offering tests that can provide information on a wide range of genetic traits and health risks. These tests can be performed at home and provide consumers with personalized information on their genetic makeup. This information can be used to make informed decisions about their health and wellness, such as making lifestyle changes or seeking out medical interventions.

Genetic testing has become increasingly popular in recent years as people seek to better understand their health and ancestry. Advances in technology have made it possible for individuals to order genetic testing kits online and perform the tests in the comfort of their own homes. These at-home genetic testing products provide people with a convenient and affordable way to learn more about their genetic makeup and potential health risks. There are many different companies that offer genetic testing kits for use at home, including 23andMe, AncestryDNA, and MyHeritage. These companies provide individuals with a simple saliva collection kit that they can use to provide a DNA sample. The samples are then sent to a laboratory for analysis, and the results are usually available within a few weeks. The tests offered by these companies can provide a wealth of information about an individual's genetic makeup. For example, they can identify specific genetic variants that are associated with an increased risk of certain diseases, such as Parkinson's disease, Alzheimer's disease, and breast cancer. They can also provide information about an individual's ancestry and genealogy, which can be helpful for those interested in tracing their family history. This, in turn, is expected to create new prospects for the growth of global self-testing market.

Market Segmentation

Global Self Testing Market can be segmented by test type, sample, usage, distribution channel, and region. Based on test type, the global self-testing market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, and others. By sample, the global self-testing market can be categorized into blood, urine, and saliva. By usage, the global self-testing market can be split into disposable and reusable. In terms of distribution channels, the global self-testing market can be segmented into retail stores/retail pharmacies, hospital pharmacies, hypermarkets/supermarket, and e-commerce channels/online pharmacies. Regionally, the global self testing market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Lucira Health, Inc., Essenlix Corporation, Abbott Laboratories, Inc., Quidel Corporation, ACON Laboratories, Inc., Scanwell Health, Inc., Johnson & Johnson, Geratherm Medical AG, B. Braun Holding GmbH, OraSure Technologies, Inc., bioLytical Laboratories Inc., Bionime Corporation, Becton, Dickinson & Company, PRIMA Lab SA, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the global Self Testing market.

Recent Developments

  • Premom launched its ovulation prediction kit in 2021, which allows women to track their fertility at home. The kit includes ovulation test strips and a smartphone app that analyzes the results to provide personalized insights into ovulation patterns and fertility status. The Premom ovulation prediction kit has been praised for its accuracy and ease of use.
  • Cue Health launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a compact device that connects to a smartphone to provide results in just 20 minutes. The Cue Health COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • Ellume, Inc. launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a small analyzer device that provides results in just 15 minutes. The Ellume COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • In 2019, 23andMe, Inc. launched its Health + Ancestry service, which provides consumers with information on their genetic traits and health risks. The service includes more than 125 reports on health conditions, such as breast cancer and heart disease, as well as carrier status for inherited conditions.
  • Abbott Laboratories, Inc. launched the Libre 2 continuous glucose monitoring (CGM) system in 2019. The device is worn on the back of the upper arm and provides real-time glucose readings and alerts for high or low blood sugar levels. The Libre 2 also has Bluetooth connectivity, allowing users to share their glucose data with healthcare providers and caregivers.

Report Scope:

In this report, Global Self Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Self Testing Market, By Test Type:

  • Blood Glucose Testing
  • Pregnancy & Fertility Testing
  • Cholesterol Testing
  • Urine Testing
  • COVID-19 Testing
  • Others

Self Testing Market, By Sample:

  • Blood
  • Urine
  • Saliva

Self-Testing Market, By Usage:

  • Disposable
  • Reusable

Self-Testing Market, By Distribution Channel:

  • Retail Stores/Retail Pharmacies
  • Hospital Pharmacies
  • Hypermarket/Supermarket
  • E-Commerce Channels/Online Pharmacies

Self-Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Self Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Self Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
    • 5.2.2. By Sample (Blood, Urine, Saliva)
    • 5.2.3. By Usage (Disposable v/s Reusable)
    • 5.2.4. By Distribution Channel (Retail Stores/Retail Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Usage
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Self Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Usage
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Self Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Usage
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Self Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Usage
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Self Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Usage
        • 6.3.3.2.4. By Distribution Channel

7. Europe Self Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Usage
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Self Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Usage
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Self Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Usage
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Self Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Usage
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Self Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Usage
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Self Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Usage
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Self Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Usage
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Self Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Usage
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Self Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Usage
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Self Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Usage
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Self Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Usage
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Self Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Usage
        • 8.3.5.2.4. By Distribution Channel

9. South America Self Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Usage
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Self Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Usage
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Self Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Usage
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Self Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Usage
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Self Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Usage
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Self Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Usage
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Self Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Usage
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Self Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Usage
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Self Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Lucira Health, Inc.
    • 15.5.2. Essenlix Corporation
    • 15.5.3. Abbott Laboratories, Inc.
    • 15.5.4. Quidel Corporation
    • 15.5.5. ACON Laboratories, Inc.
    • 15.5.6. Scanwell Health, Inc.
    • 15.5.7. Johnson & Johnson
    • 15.5.8. Geratherm Medical AG
    • 15.5.9. B. Braun Holding GmbH
    • 15.5.10. OraSure Technologies, Inc.
    • 15.5.11. bioLytical Laboratories Inc.
    • 15.5.12. Bionime Corporation
    • 15.5.13. Becton, Dickinson & Company
    • 15.5.14. PRIMA Lab SA
    • 15.5.15. F. Hoffmann-La Roche AG

16. Strategic Recommendations

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦